title: Role of the beta 3-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair.
abstract: Obesity and insulin resistance are important risk factors for the development of noninsulin-dependent diabetes (NIDDM) and are prevalent among predisposed first degree relatives of diabetic individuals. Recent molecular screening and analysis of a common missense mutation of the beta 3-adrenergic receptor gene suggested this locus as a strong candidate for increased obesity, earlier age of diabetes onset, and insulin resistance. To test the hypothesis that the beta 3-adrenergic receptor locus affects diabetes susceptibility, obesity as measured by body mass index, and components of the insulin resistance syndrome, we examined the role of this region in families ascertained for two or more NIDDM siblings. Linkage analysis was conducted using both parametric and nonparametric analyses, including multipoint sibling pair analysis. We found no evidence for linkage to NIDDM as a dichotomous trait and no evidence for linkage to body mass index, waist/hip ratio, insulin levels, or glucose levels as quantitative traits or to reported age of onset among NIDDM individuals. The Trp64 Arg missense mutation was present in 11% of the population. The mutation was not associated with NIDDM, and Arg64 carriers did not have earlier NIDDM onset, higher body mass index, or higher waist/hip ratio than Trp64 homozygotes. Among relatives, Arg64 carriers had significantly lower fasting glucose levels and lower waist/hip ratios than Trp64 homozygotes, but no characteristics of the insulin resistance syndrome. We conclude that the beta 3-adrenergic receptor locus does not play an important role in NIDDM susceptibility or in the insulin resistance syndrome among members of families with a strong predisposition to NIDDM.
authors.affiliation: Department of Medicine, Department of Veterans Affairs, Salt Lake City, Utah, USA.
authors.forename: S C
authors.initials: SC
authors.lastname: Elbein
authors.forename: M
authors.initials: M
authors.lastname: Hoffman
authors.forename: K
authors.initials: K
authors.lastname: Barrett
authors.forename: K
authors.initials: K
authors.lastname: Wegner
authors.forename: C
authors.initials: C
authors.lastname: Miles
authors.forename: K
authors.initials: K
authors.lastname: Bachman
authors.forename: D
authors.initials: D
authors.lastname: Berkowitz
authors.forename: A R
authors.initials: AR
authors.lastname: Shuldiner
authors.forename: M F
authors.initials: MF
authors.lastname: Leppert
authors.forename: S
authors.initials: S
authors.lastname: Hasstedt
mesh_terms: D000328:Adult; D000368:Aged; D002874:Chromosome Mapping; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D005260:Female; D008040:Genetic Linkage; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000235:genetics*; D010641:Phenotype; D011943:Receptors, Adrenergic, beta / Q000235:genetics*; D022702:Receptors, Adrenergic, beta-3; D044465:White People
chemical_list: D011943:Receptors, Adrenergic, beta; D022702:Receptors, Adrenergic, beta-3